Nextech Crossover I GP S.a r.l. 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-02 4:15 pm Purchase | 2023-11-01 | 13G | Ambrx Biopharma Inc. AMAM | Nextech Crossover I GP S.a r.l. | 3,129,300 5.000% | 3,129,300 (New Position) | Filing |